INOLAWYER-OS
  • INOLAWYER Advice
  • INOLAWYER Home
  • INOLAWYER Software
  • Products
  • Pricing
  • News
  • Downloads
  • EN DE
  • EN DE
BOOK A DEMO

Urbach Law advised Fairmed on a participation by Strides Pharma

Swiss based Fairmed Healthcare, a company with a portfolio of high-quality generic products, announced that it sold a majority stake to Strides Pharma Science Limited.

By Simon Urbach, Zurich

Sep 12 2019

<p><strong>Urbach Law advised Fairmed Healthcare Group with respect to a 70% participation of Strides Pharma Science Limited</strong></p><p>On September 12, 2019, <a>Fairmed Healthcare AG (Fairmed Healthcare)</a>, a Switzerland based company with a portfolio of high-quality generic products encompassing prescription and over-the-counter drugs across several therapeutic segments, announced that it sold a majority stake to <a>Strides Pharma Science Limited (Strides)</a>. The acquisition was made through subsidiary Strides Pharma Global Pte Ltd.</p><p>Strides Pharma Science Limited (Strides), is a global pharmaceutical company listed on the Bangalore Stock Exchange and National Stock Exchange of India, headquartered in Bangalore, India. Fairmed Healthcare announced that its market access in the DACH region and Strides vast international product portfolio is a highly complementary combination to pivot an extensive growth in the coming years.</p><p>Founded in Switzerland in 2012, Fairmed Healthcare aims to provide high-quality medicines at competitive prices. Fairmed Healthcare produces and markets a comprehensive range of generic prescription and OTC products for multiple indications. The headquarter is located in Zug with subsidiaries in Germany.</p><p>Urbach Law has advised Fairmed Healthcare Group in the transaction. The Urbach Law team was led by managing partner <a>Simon Urbach</a>.</p>
Call


Contact us


Teammates

Simon Urbach

Urbach Law

Stavros Koutalas

Koutalas Law

Amelie Hoffmann

Urbach Law

Rezeda Maritz

Urbach Law

Panayiotis Korakovounis

Koutalas Law


Relevant News

Was passiert mit meinem Vermögen nach meinem Tod? Welche Gestaltungsmöglichkeiten habe ich?

Was passiert mit meinem Vermögen nach meinem Tod? Welche Gestaltungsmöglichkeiten habe ich?

Oct 19 2022
Neues Erbrecht ab 2023: Was sich ändert

Neues Erbrecht ab 2023: Was sich ändert

Oct 06 2022
Urbach Law advises Fairmed Healthcare and its majority shareholder Strides Pharma on a €10 Million Debt Facility

Urbach Law advises Fairmed Healthcare and its majority shareholder Strides Pharma on a €10 Million Debt Facility

Jul 02 2021
Auswirkungen des «Brexit» auf die Fragen der Zuständigkeit und der Anerkennung und Vollstreckung von Urteilen

Auswirkungen des «Brexit» auf die Fragen der Zuständigkeit und der Anerkennung und Vollstreckung von Urteilen

Jun 15 2021
 Verzicht auf die amtliche Beglaubigung von Unterschriften bei der Prüfung von Vollmachten

Verzicht auf die amtliche Beglaubigung von Unterschriften bei der Prüfung von Vollmachten

Jan 16 2021
Vision Group AG acquires Urbach Optik AG: Urbach Law advises Urbach Optik AG and majority shareholders

Vision Group AG acquires Urbach Optik AG: Urbach Law advises Urbach Optik AG and majority shareholders

Jan 05 2021
Caution: SECO checks the legality of short-time work compensation

Caution: SECO checks the legality of short-time work compensation

Sep 18 2020
Die Tücken des Google Bewertungsportals

Die Tücken des Google Bewertungsportals

Aug 21 2020

Quick Links

Team

Pricing

Company News

Downloads

Careers

Contact

Policies

Cookie Policy

Terms of Use

Privacy Policy

INOLAWYER Software

Team

Careers

Cookie Policy

Terms of Use

Privacy Policy

Contact

INOLAWYER Software

+41 44 307 70 00

sales@inolawyer.com

INOLAWYER AG

Stockerstrasse 42

CH-8002 Zurich

Switzerland

P.O. Box, CH-8027 Zurich

Register for newsletters & updates

Follow Us:

© 2022 INOLAWYER AG. All Rights Reserved.

Cookie Policy

Terms of Use

Privacy Policy

Cookie Settings